Catalio Capital Management, LP Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$540.9B
Holdings
38
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (38 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LLYELI LILLY & CO | 57,376 | $43.8B | 8.09% | |
| 2 | ABBVABBVIE INC | 154,834 | $35.9B | 6.63% | |
| 3 | BBIOBRIDGEBIO PHARMA INC | 622,729 | $32.3B | 5.98% | |
| 4 | ISRGINTUITIVE SURGICAL INC | 71,343 | $31.9B | 5.90% | |
| 5 | ASNDASCENDIS PHARMA A/S | 144,954 | $28.8B | 5.33% | |
| 6 | SLNOSOLENO THERAPEUTICS INC | 418,245 | $28.3B | 5.23% | |
| 7 | DNTHDIANTHUS THERAPEUTICS INC | 667,615 | $26.3B | 4.86% | |
| 8 | BSXBOSTON SCIENTIFIC CORP | 262,972 | $25.7B | 4.75% | |
| 9 | SNDXSYNDAX PHARMACEUTICALS INC | 1,614,717 | $24.8B | 4.59% | |
| 10 | CYTKCYTOKINETICS INC | 451,581 | $24.8B | 4.59% | |
| 11 | NTRANATERA INC | 148,369 | $23.9B | 4.42% | |
| 12 | REGNREGENERON PHARMACEUTICALS | 35,344 | $19.9B | 3.67% | |
| 13 | GPCRSTRUCTURE THERAPEUTICS INC | 651,810 | $18.3B | 3.37% | |
| 14 | QUREUNIQURE NV | 282,940 | $16.5B | 3.05% | |
| 15 | IRONDISC MEDICINE INC | 216,527 | $14.3B | 2.65% | |
| 16 | ABVXABIVAX SA | 162,141 | $13.8B | 2.54% | |
| 17 | SUPNSUPERNUS PHARMACEUTICALS INC | 287,090 | $13.7B | 2.54% | |
| 18 | EXASEXACT SCIENCES CORP | 248,987 | $13.6B | 2.52% | |
| 19 | PHATPHATHOM PHARMACEUTICALS INC | 1,128,521 | $13.3B | 2.46% | |
| 20 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 884,890 | $13.2B | 2.45% | |
| 21 | RNAAVIDITY BIOSCIENCES INC | 263,256 | $11.5B | 2.12% | |
| 22 | ADMAADMA BIOLOGICS INC | 684,508 | $10.0B | 1.86% | |
| 23 | RAREULTRAGENYX PHARMACEUTICAL IN | 291,262 | $8.8B | 1.62% | |
| 24 | GUTSFRACTYL HEALTH INC | 5,214,236 | $8.3B | 1.53% | |
| 25 | GRALGRAIL INC | 137,928 | $8.2B | 1.51% | |
| 26 | TARAPROTARA THERAPEUTICS INC | 1,500,793 | $6.5B | 1.21% | |
| 27 | SEPNSEPTERNA INC | 294,360 | $5.5B | 1.02% | |
| 28 | CDTXCIDARA THERAPEUTICS INC | 53,333 | $5.1B | 0.94% | |
| 29 | KYTXKYVERNA THERAPEUTICS INC | 586,909 | $3.5B | 0.65% | |
| 30 | ELDNELEDON PHARMACEUTICALS INC | 1,061,132 | $2.7B | 0.51% | |
| 31 | OMOUTSET MED INC | 118,279 | $1.7B | 0.31% | |
| 32 | MGXMETAGENOMI INC | 528,993 | $1.3B | 0.23% | |
| 33 | ATAIATAI LIFE SCIENCES NV | 196,858 | $1.0B | 0.19% | |
| 34 | HYPRHYPERFINE INC | 684,541 | $992.6M | 0.18% | |
| 35 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 133,131 | $954.5M | 0.18% | |
| 36 | KPTIKARYOPHARM THERAPEUTICS INC | 142,984 | $935.1M | 0.17% | |
| 37 | PVLAPALVELLA THERAPEUTICS INC NE | 12,010 | $752.9M | 0.14% | |
| 38 | SNSESENSEI BIOTHERAPEUTICS INC | 14,718 | $139.1M | 0.03% |